Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy

Online download statistics by month:

Online download statistics by month: May 2024 to March 2026

	Abstract	Full	Pdf
May 2024	1138	1149	413
Jun 2024	846	859	222
Jul 2024	302	308	131
Aug 2024	153	153	74
Sep 2024	133	135	187
Oct 2024	128	130	194
Nov 2024	153	154	81
Dec 2024	171	175	91
Jan 2025	154	155	95
Feb 2025	252	254	77
Mar 2025	159	160	180
Apr 2025	143	143	82
May 2025	123	123	58
Jun 2025	72	72	43
Jul 2025	1	1	0
Aug 2025	1	0	0
Sep 2025	2	2	1
Feb 2026	1	1	0
Total	3932	3974	1929